PrecivityAD2™ | Alzheimer's Disease | beta-amyloid plaques

HK$16,000.00

The PrecivityAD2™ testing technology developed by C2N Diagnostics embodies the philosophy of “Answers from the brain — and clues are found in the blood." It offers a unique and highly valuable approach.

This testing technology enables clear detection of beta-amyloid plaques in the brain. In the mechanisms of brain health and disease progression, beta-amyloid plaques are a critically important factor — they are also a key pathological hallmark of Alzheimer’s disease. By capturing and analyzing relevant clues in the blood, PrecivityAD2™ provides highly targeted and powerful support for the diagnosis, research, and application related to Alzheimer’s disease.

Quantity

This service is only available with a doctor's referral.
If you need assistance, please call 3008 2560 or email us at support@codexgenetics.com.
After your blood draw is completed, our staff will collect the blood sample and deliver it to our laboratory. You do not need to—and should not—take the blood sample away from the clinic yourself.

Once our laboratory receives your blood sample and confirms that the sample quality meets the standards for testing, you will receive an email notification and be able to track the testing progress on this online platform.
Once our laboratory receives your blood sample and confirms that the sample quality meets the standards for testing, the estimated report turnaround time will begin from the date the sample is deemed suitable for testing.

Estimated report turnaround time for this test: 4 working weeks.

When your test report is ready, you will receive an email notification. The report will be sent to the clinic where you placed your order, and your doctor will explain the results to you.
If you have any special delivery or collection requests, please contact our customer service team after your order is confirmed.